Hyperlipidemia Drugs Market Share, Size, Growth, Opportunities, Industry Analysis And Forecast 2020 To 2025
Hyperlipidemia refers to a health condition where an excessive quantity of lipids, such as cholesterol and triglycerides, is produced into the blood. This condition may lead to cardiac stroke, peripheral vascular disorders, atherosclerosis, diabetes, obesity, hypertension, and various cardiovascular diseases. Some of the hyperlipidemia drugs include statins, bile acid sequestrants, cholesterol absorption inhibitors, PCSK9 inhibitors, fibric acid derivatives, etc. These drugs help in reducing cholesterol production levels in the liver along with lowering the quantity of lipids from the bloodstream.
The rising prevalence of numerous lifestyle disorders, such as hypertension, obesity, cardiovascular diseases, etc., due to sedentary consumer lifestyles, is driving the demand for hyperlipidemia drugs. Furthermore, the increasing geriatric population who are more prone to the risk of high cholesterol and cardiovascular diseases, is also augmenting the market growth. Additionally, the development of novel drug classes with improved endothelial function and stable atherosclerotic plaques is further propelling the demand for hyperlipidemia drugs. Besides this, the reduction in the prices of PCSK9 inhibitors, such as Repatha and Praluent, is expected to replace several expensive therapies, thereby catalyzing the global market for hyperlipidemia drugs.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/hyperlipidemia-drugs-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Hyperlipidemia Drugs Market 2020-2025 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the key players being Amgen Inc., AstraZeneca PLC, Daiichi Sankyo Company Limited, Eli Lilly and Company, Esperion Therapeutics Inc., GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc), Immuron Limited, Ionis Pharmaceuticals Inc., Merck & Co. Inc., Pfizer Inc. and Sanofi S.A.
For more information about this report visit: https://www.imarcgroup.com/hyperlipidemia-drugs-market
The report has segmented the market on the basis of Drug Type, End User and Region.
Breakup by Drug Type:
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Fibric Acid Derivatives
Breakup by End User:
Breakup by Region:
Middle East and Africa
Browse related reports
Biopreservation Market: https://www.imarcgroup.com/biopreservation-market
DNA Sequencing Products Market: https://www.imarcgroup.com/dna-sequencing-products-market
Artificial Organs Market: https://www.imarcgroup.com/artificial-organs-market
Japan Generic Drug Market: https://www.imarcgroup.com/japan-generic-drug-market
GCC Generic Drug Market: https://www.imarcgroup.com/gcc-generic-drug-market
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Follow us on twitter: @imarcglobal
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperlipidemia Drugs Market Share, Size, Growth, Opportunities, Industry Analysis And Forecast 2020 To 2025 here
News-ID: 2198036 • Views: 453
More Releases from IMARC Group
Global Health Insurance Market Report 2021: Share, Current Trends, Opportunities …
According to the latest report by IMARC Group, titled, “Health Insurance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025", the global health insurance market grew at a CAGR of around 5% during 2015-2020. Health insurance refers to a type of insurance that periodically charges a predefined amount from the individual and pays for medical and surgical expenses incurred by the policyholder in case of a medical emergency. A
Modular Instruments Market Research 2020-2025: Profitable Customized Report
According to the latest report by IMARC Group, titled “Modular Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global modular instruments market size reached US$ 1.4 Billion in 2019. Modular instruments are devices used for configuring automated test and measurement (T&M) equipment, which assist in the designing, developing, maintaining, verifying and repairing of different electronic and mechanical products. These instruments have a frame in which
China Pollution Mask Market Research 2020-2025: Profitable Customized Report
According to the latest report by IMARC Group, titled “China pollution mask Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the pollution mask market in china grew at a CAGR of 10% during 2014-2019. Pollution masks are used as a protective face covering for filtering out air pollutants. These masks are essentially required to prevent chronic respiratory conditions, such as asthma, lung infection, COPD, etc. Pollution masks are
Asia Pacific Biometrics Market Research 2020-2025: Profitable Customized Report
According to the latest report by IMARC Group, titled “Asia Pacific Biometrics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the Biometrics market size in Europe reached a strong growth in 2019. Biometrics refers to a security component that helps in authenticating the identity of individuals based on their physical or behavioral characteristics. It is commonly bifurcated into physiology- and behavior-based biometrics. Physiological characteristics for biometrics majorly include
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Inhalation Drug Delivery Devices Market
Boston, MA ReportsWorldwide has announced the addition of a new report title Inhalation Drug Delivery Devices Market to its growing collection of premium market research reports. The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug delivery devices totaled nearly $11.7bn in 2016, and
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals